Clinical trial
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and…
NCT00151775 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00151775 |
|---|---|
| Title | Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure |
| Official title | Dose-ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents With Hypertension |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | olmesartan medoxomil, placebo |
| Enrollment | 362 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Jun 30, 2016 |
| Countries | Argentina, Brazil, Chile, Colombia, India, Kenya, Peru, South Africa, Uganda, United States, Zambia |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: